Solving RNA structures unlocks new paths for therapeutic discovery. Our platform combines structural biology, computational modeling, and experimental validation to identify and advance high-confidence RNA targets.
Our platform is designed to make RNA a tractable and scalable target class for drug discovery. By combining structural insight with integrated screening and optimization, we enable programs that were previously out of reach.
